TT

T2 Biosystems

- NASDAQ:TTOO
Last Updated 2024-03-26

LinkedIn Profile

Access T2 Biosystems historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:ttoo 520960 Mar 23rd, 2024 12:00AM T2 Biosystems 10K 146.00 Open Mar 23rd, 2024 12:48AM Mar 23rd, 2024 07:30PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 22nd, 2024 12:00AM T2 Biosystems 10K 146.00 Open Mar 22nd, 2024 12:20AM Mar 22nd, 2024 07:19PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 21st, 2024 12:00AM T2 Biosystems 10K 146.00 Open Mar 21st, 2024 06:03PM Mar 21st, 2024 06:03PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 20th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Mar 20th, 2024 02:04AM Mar 20th, 2024 08:04PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 19th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Mar 19th, 2024 12:01AM Mar 19th, 2024 06:36PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 18th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Mar 18th, 2024 12:46AM Mar 18th, 2024 07:48PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 16th, 2024 12:00AM T2 Biosystems 10K 146.00 Open Mar 15th, 2024 11:52PM Mar 16th, 2024 07:35PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 15th, 2024 12:00AM T2 Biosystems 10K 147.00 Open Mar 15th, 2024 07:31AM Mar 15th, 2024 09:26AM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 14th, 2024 12:00AM T2 Biosystems 10K 147.00 Open Mar 13th, 2024 11:51PM Mar 14th, 2024 12:48PM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services
nasdaq:ttoo 520960 Mar 13th, 2024 12:00AM T2 Biosystems 10K 148.00 Open Mar 12th, 2024 11:45PM Mar 13th, 2024 11:18AM T2 Biosystems is developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, T2 Biosystems is an emerging leader in the field of in vitro diagnostics. Our initial development efforts target sepsis, hemostasis, bacteria and Lyme disease, which are areas of significant unmet medical need. The Company is utilizing its proprietary T2 Magnetic Resonance platform, or T2MR®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. At T2 Biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. We invite you to apply for one of our open positions at www.t2biosystems.com/careers. Open Sepsis, Hemostasis, Infectious Diseases, Candidemia, and In-vitro diagnostics Open 101 Hartwell Avenue Lexington MA US 02421 T2 Biosystems Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.